C-Glucosides with heteroaryl thiophene as novel sodium-dependent glucose cotransporter 2 inhibitors.

[1]  T. Ishikawa,et al.  Aryl-β-C-glucosidation using glucal boronate: application to the synthesis of tri-O-methylnorbergenin , 2012 .

[2]  D. Loo,et al.  Biology of human sodium glucose transporters. , 2011, Physiological reviews.

[3]  Y. Koga,et al.  Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus. , 2010, Journal of medicinal chemistry.

[4]  R. Henry,et al.  SGLT2 inhibition — a novel strategy for diabetes treatment , 2010, Nature Reviews Drug Discovery.

[5]  H. Koepsell,et al.  SGLT2 mediates glucose reabsorption in the early proximal tubule , 2010, Journal of the American Society of Nephrology : JASN.

[6]  Richard Donnelly,et al.  Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug , 2009, Diabetes, obesity & metabolism.

[7]  R. DeFronzo,et al.  Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitus. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[8]  B. Goldstein,et al.  Sodium glucose co‐transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes , 2008, International journal of clinical practice.

[9]  W. Humphreys,et al.  Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. , 2008, Journal of medicinal chemistry.

[10]  B. Conway,et al.  Glycosylated dihydrochalcones as potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitors. , 2004, Bioorganic & medicinal chemistry letters.

[11]  Y. Kondo,et al.  Mesityllithium as a reagent for chemoselective halogen-lithium exchange reaction. , 2001, Organic letters.

[12]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[13]  Y. Mitsumoto,et al.  Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells. , 1991, Biochemical and biophysical research communications.

[14]  M. Nishimura,et al.  Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. , 2005, Drug metabolism and pharmacokinetics.

[15]  S. Bowlin,et al.  Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. , 2004, Diabetes care.